Lori Firmani

VP of Finance and Treasurer, F-star Therapeutics, Inc.

Companies

Damora Therapeutics, Inc.Chief financial officer Aug 16, 2024 to now¹
F-star Therapeutics, Inc.VP of Finance and Treasurer Apr 24, 2020 to Nov 23, 2020²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Damora Therapeutics, Inc. DMRA931 shares³$17.1K at $18.32Jan 2, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Jan 2, 2026Sold 135 shares at $21.41 of Damora Therapeutics, Inc.³
Jan 2, 2026Exercised options 374 shares of Damora Therapeutics, Inc.³
Jul 3, 2025Sold 147 shares at $3.39 of Damora Therapeutics, Inc.⁴
Jul 3, 2025Exercised options 374 shares of Damora Therapeutics, Inc.⁴
Jan 3, 2025Sold 261 shares at $5.63 of Damora Therapeutics, Inc.⁵
Jan 3, 2025Exercised options 726 shares of Damora Therapeutics, Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARDamora Therapeutics, Inc., Chief financial officer
2
SEC EDGARF-star Therapeutics, Inc., VP of Finance and Treasurer
3
SEC EDGARDamora Therapeutics, Inc. shares after the filing of Jan 2, 2026
4
SEC EDGARForm 4 filed Jul 8, 2025
5
SEC EDGARForm 4 filed Jan 7, 2025